Amanote Research
Register
Sign In
miR-186 Reverses Cisplatin Resistance and Inhibits The�formation of the Glioblastoma-Initiating Cell�phenotype by Degrading Yin Yang 1 in Glioblastoma
International Journal of Molecular Medicine
- Greece
doi 10.3892/ijmm.2018.3940
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Genetics
Date
October 18, 2018
Authors
Jian Li
Jie Song
Feng Guo
Publisher
Spandidos Publications
Related search
miR‑96 Inhibits EMT by Targeting AEG‑1 in Glioblastoma Cancer Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
miR-375 Inhibits Cancer Stem Cell Phenotype and Tamoxifen Resistance by Degrading HOXB3 in Human ER-positive Breast Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
miR-124 Inhibits the Growth of Glioblastoma Through the Downregulation of SOS1
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
miR-15b Inhibits Cancer-Initiating Cell Phenotypes and Chemoresistance of Cisplatin by Targeting TRIM14 in Oral Tongue Squamous Cell Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Therapeutic Targeting of Constitutive PARP Activation Compromises Stem Cell Phenotype and Survival of Glioblastoma-Initiating Cells
Cell Death and Differentiation
Cell Biology
Molecular Biology
Restoration of miR-26b Expression Partially Reverses the Cisplatin Resistance of NSCLC by Targeting Tafazzin
OncoTargets and Therapy
Oncology
Pharmacology
Mechanisms of Cell Resistance in Glioblastoma Multiforme
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Targeting the Overexpressed Yin Yang 1 in Cancer Inhibits EMT and Metastasis
Critical Reviews in Oncogenesis
Cancer Research
Disrupting the PIKE-A/Akt Interaction Inhibits Glioblastoma Cell Survival, Migration, Invasion and Colony Formation
Oncogene
Cancer Research
Genetics
Molecular Biology
